Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.05 USD | -0.18% | +2.03% | -45.54% |
Apr. 30 | UBS Adjusts ACADIA Pharmaceuticals' Price Target to $27 From $33, Keeps Buy Rating | MT |
Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
- Stock Market
- Equities
- ACAD Stock
- News ACADIA Pharmaceuticals Inc.